ITEMS IN AFP WITH KEYWORD:
Case study: E.B. is a 50-year-old black woman who comes to your office for weight-loss counseling. She reports that her brother recently had a heart attack at 58 years of age. She does not smoke and takes no medications other than a daily multivitamin.
Dec 1, 2009 Issue
Screening for Lipid Disorders in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
Screening men: The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening men 35 years and older for lipid disorders.
Apr 15, 2009 Issue
AAP Clinical Report on Lipid Screening in Children [Practice Guidelines]
The American Academy of Pediatrics (AAP) released a clinical report in July 2008 that recommends lipid screening in children and adolescents with a fasting lipid profile, and focuses on improving childhood and adolescent lipid and lipoprotein concentrations to lower the lifetime risk of cardiovascular disease.
Photo Quiz presents readers with a clinical challenge based on a photograph or other image.
The American Heart Association (AHA) has published a scientific statement on drug therapy for the treatment of high-risk lipid abnormalities in children and adolescents.
Hypertriglyceridemia is associated with an increased risk of cardiovascular events and acute pancreatitis. Along with lowering low-density lipoprotein cholesterol levels and raising high-density lipoprotein cholesterol levels, lowering triglyceride levels in high-risk patients (e.g., those with card...
Apr 1, 2006 Issue
CDC Reports on Trends in Cholesterol Screening and Awareness [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has published a report on the prevalence of cholesterol screening and awareness using data from the Behavioral Risk Factor Surveillance System.
Low doses of ezetimibe/simvastatin provide greater improvements in lipid profile than simvastatin or atorvastatin monotherapy. Ezetimibe/simvastatin may be useful in patients who are unable to tolerate high-dose statin therapy. Combination ezetimibe-simvastatin is less expensive than adding ezetimib...
Colesevelam lowers LDL cholesterol levels a small amount (7 to 16 percent) when used alone and provides additional cholesterol lowering when added to statin therapy. It has a slightly beneficial effect on HDL cholesterol levels, has no effect on triglyceride levels, and is well tolerated.
Cardiovascular disease and its subset coronary heart disease are leading causes of morbidity and mortality in the United States and worldwide. In general, higher levels of low-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease, myocardial infarction, and ...